Onkologie. 2015:9(1):43-45

Chyloperitoneum - a case report

Gabriel Jelenek, Monika Náležinská
Masarykův onkologický ústav, Brno

Chylous ascites is a rare complication of oncogynaecological surgery in retroperitoneum as a result of systematic pelvic and paraaortal

lymphadenectomy. Therapeutical approach is highly individual, primary conservative with accent to dietary restriction and leading

to results in 4–8 weeks. In case of failure, surgical therapy is indicated and can be first in line with high rate of curability if location of

extravasation of chylus is detected.

nutrition, paracenthesis.

Keywords: chyloperitoneum, chylous ascites, extravasation of chylus, chylus, lymphadenectomy, somatostatin, octreotid, total parenteral

Published: March 10, 2015  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Jelenek G, Náležinská M. Chyloperitoneum - a case report. Onkologie. 2015;9(1):43-45.
Download citation

References

  1. Combe J, Buniet JM, Douge C, Bernard Y, Camelot G. Chylothorax and chylous ascites following surgery of an inflammatory aortic aneurysm. Case report with review of the literature. J Mal Vasc 1992; 17(2): 151-156. Go to PubMed...
  2. Frey MK, Ward NM, Caputo TA, Taylor J, Worley Jr MJ, Slomovitz BM. Lymphatic ascites following pelvic and paraaortic lymphadenectomy procedures for gynecologic malignancies. Gynecol Oncol 2012; 125(1): 48-53. Go to original source... Go to PubMed...
  3. Aalami OO, Allen DB, Organ Jr CH. Chylous ascites: a collective review. Surgery 2000; 128(5): 761-778. Go to original source... Go to PubMed...
  4. Ablan CJ, Littooy FN, Freeark RJ. Postoperative chylous ascites: diagnosis and treatment. A series report and literature review. Arch Surg 1990; 125(2): 270-273. Go to original source... Go to PubMed...
  5. Chatila R, Ferayorni L, Gupta T, Groszmann RJ. Local arterial vasoconstriction induced by octreotide in patients with cirrhosis. Hepatology 2000; 31: 572-576. Go to original source... Go to PubMed...
  6. Collard JM, Laterre PF, Boemer F, Reynaert M, Ponlot R. Conservative treatment of postsurgical lymphatic leaks with somatostatin-14. Chest 2000; 117: 902-905. Go to original source... Go to PubMed...
  7. Halachmi S, Noyman A, Moskovitz B, Nativ O. Successful treatment of postretroperitoneal lymph node dissection in massive chylous ascites. Eur Urol 1995; 28: 119-121. Go to original source... Go to PubMed...
  8. Baniel J, Foster RS, Rowland RG, Bihrle R, Donohue JP. Management of chylous ascites after retroperitoneal lymph node dissection for testicular cancer. J Urol 1993; 150(5 Pt 1): 1422-1424. Go to original source... Go to PubMed...
  9. Tulunay G, Ureyen I, Turan T, Karalok A, Kavak D, Ozgul N, Ocalan R, Tapisiz OL, Boran N, Kose MF, Chylous ascites: Analysis of 24 patients. Gynecol Oncol 2012; 127(1): 191-197. Go to original source... Go to PubMed...
  10. Shibuya Y, Asano K, Hayasaka A, Shima T, Akagi K, Ozawa N, Wada Y. A novel therapeutic strategy for chylous ascites after gynecological cancer surgery: a continuous low-pressure drainage system. Arch Gynecol Obstet (2013) 287: 1005-1008. Go to original source... Go to PubMed...
  11. Sachs, PB, Zelch MG, Rice TW, et al. Diagnosis and localisation of laceration of the thoracic duct. usefulness of lymphangiography and CT. AJR Am J Roentgenol 1991; 157: 703. Go to original source... Go to PubMed...
  12. Takeuchi S, Kinoshita H, Terasawa K, Minami S. Chylous ascites following operation for para-aortic lymph node dissection in a patient with cervical cancer. Int J Gynecol Cancer 2006; 16(Suppl. 1): 418-422. Go to original source... Go to PubMed...
  13. Molina WR, Desai MM, Gill IS. Laparoscopic management of chylous ascites after donor nephrectomy. J Urol 2003; 170: 1938. Go to original source... Go to PubMed...
  14. Han D, Wu X, Li J, Ke G. Postoperative chylous ascites in patients with gynecologic malignancies. Int J. Gynecol Cancer 2012; 22(2): 186-190. Go to original source... Go to PubMed...




Oncology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.